Ahmedabad,Gujarat,India India
A business house catering to needs of Pharmaceutical Industry for APIs (Active Pharmaceutical Ingredients), Finished Formulations & Intermediates. The company has grown many folds since ***6 into a group of companies and is growing leaps and bounds. With ever lust to expand, the company is fast growing in field of Indenting and Strategic Sourcing Activities.
The People
The company is managed by technical persons having multifaceted experience in Pharmaceutical Industry. It is their constant endeavor to satisfy the need of their clientele in the best possible manner. Besides, they are constantly engaged in identifying new business opportunities by keeping abreast of market requirements in Pharmaceutical and Healthcare sector. It is this attitude, which has helped to build a long-lasting relationship with our customers and suppliers. On the suppliers front, we have managed to develop symbiotic relationships with suppliers for mutual benefit. The bridge created by continuous exchange of information between supplier and customers has helped us to satisfy our customers and suppliers as well.
We Are Looking For
At Medilink we believe in building relationships for mutual benefit. We are looking for Manufacturers/their representatives who wish to market their products in India.
We welcome
With Our backing of Principals who are very quality oriented companies, we welcome Companies/Agents who are looking to source APIs, Intermediates and Finished formulations from India. Our principals are in to delivering of quality products fulfilling all regulatory requirements across the globe. We assure to prove ourselves as Best Sourcing Partner for sourcing your Pharmaceutical requirements from India with a clear glass policy between customer and suppliers acting as perfect intermediate channel.
SERVICES :*->
Indenting
Indian companies now manufacture *5% of the active pharmaceutical ingredients (API) required by the country and account for *0% of the pharmaceutical exports. The Indian pharmaceutical sector has made the country self sufficient in almost all the **0 essential drugs through indigenous process technology.
The Indian pharmaceutical industry has emerged as a formidable player in the API and key intermediates market. India offers a strong manufacturing base at competitive costs, supported by a well-developed engineering pool and an abundance of scientific talent
After having worked as dealers, importer & exporters since ***6 we have parallely stepped into field of indenting for local as well as foreign companies since ***7. Because of our broad initial experience with the industry We have succeeded a lot in field of indenting satisfying our principals up to their desire. At Medilink we believe in building relationships for mutual benefit. We are looking for Manufacturers/their representatives who wish to market their products in India.
Sourcing
India's pharmaceutical industry has been growing at record levels in recent years but now has unprecedented opportunities to expand in a number of fields. The domestic industry's long-established position as a world leader in the production of high-quality generic medicines is set to reap significant new benefits as the patents on a number of blockbuster drugs are scheduled to expire over the next few years. In addition, more and more governments worldwide are seeking to curb their soaring prescription drug costs through greater use of generics. These opportunities are presenting themselves not only in India's traditional wealthy client markets such as the U.S. and European Union nations but also in emerging economies with vast populations such as Africa, South America, Asia, and Eastern and Central Europe.
In addition, India's long-established position as a preferred manufacturing location for multinational drug manufacturers is quickly spreading into other areas of outsourcing activities. Soaring costs of R&D and administration are persuading drug manufacturers to move more and more of their discovery research and clinical trials activities to the subcontinent or to establish administrative centers there, capitalizing on India's high levels of scientific expertise as well as low wages.
With Our backing of Principals who are very quality oriented companies, we at Medilink welcome Companies/Agents who are looking to source APIs, Intermediates and Finished formulations from India. Our principals are in to delivering of quality products fulfilling all regulatory requirements across the globe. We assure to prove ourselves as Best Sourcing Partner for sourcing your Pharmaceutical requirements from India with a clear glass policy between customer and suppliers acting as perfect intermediate channel.
Contract Manufacturing
The global pharmaceutical market is estimated to represent a
$*8 billion opportunity for India by ***1, in terms of:
• manufacturing outsourcing-supply of active pharmaceutical
ingredients (APIs) and intermediates
• development outsourcing-conducting preclinical and clinical
trials
• customized chemistry services-contract research services for
compounds pre-launch.
Worldwide revenues for pharmaceutical industry contract manufacturing and research services (CRAMS) totaled $**0 billion in ***4 and will grow at an average annual rate of *0.8 percent to reach $**8 billion by ***9, say analysts at Frost & Sullivan. Within this total, the global market for contract manufacturing of prescription drugs is estimated to increase from a value of $*6.2 billion to $*3.9 billion, although the over-the-counter medicines and nutritional products sector will show the fastest growth.*1 The Asian region has recently been challenging North America and Europe's traditional domination of the global pharmaceutical contract manufacturing market: India and China could potentially account for *5 percent to *0 percent of the outsourced market share for active pharmaceutical ingredients, finished dosage formulations and intermediates.*2
Two major developments suggest that Indian drug manufacturers are set to benefit from an outsourcing boom. First, such an upsurge in business always occurs when a number of top-selling drugs come off-patent, as is about to happen. Second, the arrival of India's product patent regime has increased international companies' confidence in India's outsourcing industry.
We ate Medilink forward our hand to companies looking for Out Sourcing their Pharmaceutical needs with World class Standards from India, by helping and working them out with perfect partners in India.
Business Type
Exporters
Website
www.medilinkpharma.com
Year Established
1996
Number of Employees
16-25
Main Markets
Americas,Africa,Asia,Caribbean,America,Middle East
Products / Services
pharmaceutical chemicals, active pharmaceutical ingredients, intermediates for apis, herbal extracts
Factory Location
N/A
Factory Size
N/A
No. of Production Lines
0
Total Annual Purchase Volume
N/A
No. of R&D Staff
N/A
Quality Control
N/A
Certificates
N/A
Contract Manufacturing
N/A
Registered Capital
10 - 25 Million USD
Ownership Type
Partnership
Legal Representative / CEO
JETRA DILIPKUMAR CHOKSHI
Export Percentage
50
Total Annual Sales Volume
25 - 50 Million USD
No. of QC Staff
N/A
Contact Person
JETRA
Company
MEDILINK PHARMACHEM
Address
Ahmedabad, Gujarat, India